Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 28, 2026Kidney International ReportsOpen Access

Wcn26-2145 Impact of Histology on Efficacy of Sparsentan Therapy in Iga Nephropathy: Central Biopsy Review of Patients in the Protect Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlex MercerBHBruce HendrySMStephanie Moody

Discussion

Loading...

Member takes

Overview

Case highlights efficacy of telitacicept in kidney and neuromuscular conditions, suggesting dual benefits.

Key Points

  • This research investigates how different histological types affect the efficacy of sparsentan therapy in IgA nephropathy.
  • Conducted a central biopsy review of patients enrolled in the PROTECT trial.
  • Analyzed the histological variations among subjects receiving sparsentan therapy.
  • Assessed the impact of these variations on treatment outcomes.
  • Telitacicept showed potential benefits in managing renal autoimmunity.
  • The therapy demonstrated efficacy in addressing antibody-mediated dysfunctions.
  • Findings indicate a need for personalized treatment approaches based on histology.

Cite This Study

Mercer et al. (2026) studied this question.

synapsesocial.com/papers/69c770c08bbfbc51511e0b36https://doi.org/10.1016/j.ekir.2026.104302
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual BAFF/APRIL inhibition with telitacicept in systemic lupus erythematosus and IgA nephropathy: pharmacological rationale, clinical efficacy, and safety on female fertility preservation2026
  2. 2Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study2025 · 6 citations
  3. 3Telitacicept targets Gd-IgA1 and autoantibody-producing B cells in IgA nephropathy2026 · 4 citations
  4. 4#1170 Efficacy and safety of telitacicept in IgA nephropathy: a real-world study2024 · 3 citations
  5. 5Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report2025 · 2 citations